SCHEMBL8832004

SCHEMBL8832004

Brc1ccc2c(c1)[nH]c1nc3ccccc3nc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.65
CASP7 P55210 3/20 0.65
NPC1 O15118 2/20 0.65
TP53 P04637 2/20 0.65
CASP1 P29466 2/20 0.65
MAPK10 P53779 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
POLB P06746 1/20 0.65
MAPT P10636 3/20 0.52
CYP2C19 P33261 3/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP1A2 P05177 2/20 0.52
MAPK1 P28482 1/20 0.52
NQO2 P16083 3/20 0.45
PTGES O14684 7/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PABPC1 P11940 1/20 0.42
ADORA2A P29274 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832011 0.84 NPC1 (0.71) RAB9ACASP7NPC1TP53CASP1
SCHEMBL29572859 0.79 RAB9A (1.00) RAB9ACASP7NPC1TP53CASP1
SCHEMBL278729 0.79 RAB9A (1.00) RAB9ACASP7NPC1TP53CASP1
SCHEMBL3257680 0.76 NPC1 (0.58) RAB9ACASP7NPC1TP53CASP1
SCHEMBL9436884 0.75 RAB9A (0.62) RAB9ACASP7NPC1TP53CASP1
SCHEMBL16945136 0.73 NQO2 (0.55) MAPTMAPK1NQO2KDM4EALDH1A1
SCHEMBL13647624 0.73 NQO2 (0.55) MAPTMAPK1NQO2PTGESPDPK1
SCHEMBL14092955 0.73 PTGES (0.37) CYP2C19CYP3A4CYP2C9MAPK1PTGES
SCHEMBL14092954 0.73 MAPT (0.40) POLBMAPTCYP2C19CYP3A4CYP2C9
SCHEMBL9706105 0.72 MAPK1 (0.51) RAB9ACASP7NPC1TP53CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 EP disclosed